Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
View/Download PDF

Translate this page into:

49 (); 1-5
doi:
10.1016/j.jor.2023.11.035

Does central sensitization correlate with two-year postoperative functional outcome scores following hip arthroscopy?

Rothman Orthopaedic Institute, Philadelphia, PA, USA

∗Corresponding author: Andres R. Perez. andres.perez@rothmanortho.com

Disclaimer:
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Central sensitization (CS) involves amplified central nervous system (CNS) signaling and several biochemical changes which lead to pain hypersensitivity. Data on the effects of CS are limited in orthopaedics and has been associated with reported levels of postoperative pain after hip arthroscopy.

Patients over the age of 18 who underwent hip arthroscopy with preoperative as well as 2-year postoperative functional outcome scores were identified through the Multicenter Arthroscopic Study of the Hip (MASH) database. Patient demographics, procedure information, as well as patient reported outcome measures (PROMs) were collected along with CS index scores.

34 patients met inclusion criteria for our study. Preop MCS and iHOT as well as Postop MCS, showed moderate to strong negative correlations with CSI scores (−0.607, −0.573, and −0.756, respectively). VAS, PCS and MSC scores were significantly different preoperatively to postoperatively, ensuring alleviation of pain after hip arthroscopy. Subgroup analysis by stratifying CSI scores into 1 SD below the mean, within 1 SD of the mean, and above 1 SD showed significant differences across all 3 groups for preoperative MCS (p < 0.001), postoperative MCS (p = 0.001), and PSEQ2 (p = 0.015). Postoperative VAS pain approached significance but did not meet criteria of p < 0.05 (p = 0.062).

Increased postoperative CSI scores directly correlated with decreased preoperative and postoperative MCS scores and worse preoperative resilience. Recognizing the influence of CS on pain perception and resilience on coping with adversity in the recovery period may guide orthopaedic surgeons in developing comprehensive treatment plans to continue to improve surgical outcomes in hip arthroscopy.

IV.

Keywords

Hip arthroscopy
Central sensitization
Pain sensitivity
Resilience
Patient reported outcomes
1

1 Introduction

Central sensitization (CS) involves amplified central nervous system (CNS) signaling and several biochemical changes which lead to pain hypersensitivity.1,2 As opposed to a simplified view of the pain response, where a peripheral stimulus (e.g. object, heat, or injury) causes a severity of pain proportional to the stimulus, CS builds upon this by accounting for the role of the CNS as well. The CNS can alleviate or amplify pain severity as well as increase or decrease the duration of pain perception.1

Data on the effects of central sensitization in orthopaedics is limited. Regarding surgical outcomes, two studies have examined the use of the Central Sensitization Index (CSI). Coronado et al. found that CSI scores were associated with resilience, anxiety, and negative affect in patients with unilateral shoulder pain, but were not associated with widespread pain sensitivity.3 However, Kondo et al. found that CS significantly affected neck pain and disability in patients undergoing surgery for cervical degenerative disk disease.4

While understanding the effect of CS on acute surgical outcomes is clinically relevant, studying the role that it plays in chronic pain is equally important. However, this can be difficult as current research suggests that the effect of CS on pain differs by disease. Mibu et al. found that CSI and widespread pain index (WPI) scores were significantly higher in patients with chronic low back pain compared to patients with knee osteoarthritis despite the fact that there was no difference in subjective pain intensity between groups.5 Further, they found that pain-related disability and health related quality of life scores were associated with CSI in both groups. From these findings, they suggested that there be disease-specific CS cutoff scores.4,5 Somewhat similarly, multiple studies have examined the modulation of pain in patellofemoral pain (PFP). De Albuquerque et al. compared women with PFP to asymptomatic women and found that the PFP group had lower pressure pain thresholds in both the knee and the elbow, but there was no difference in conditioned pain modulation.6 Maclachlan et al. noted similar findings, while also noting the prevalence and importance of psychological comorbidities, such as pain-related fear in PFP.7

A recent level IV study by Bech et al. found that CSI was associated with the reported levels of postoperative pain after hip arthroscopy.8 However, this study only followed up with patients up to 12 weeks from their surgery date. To our knowledge, no higher level prognostic studies have been performed. Therefore, the purpose of this study is to retrospectively investigate the effect that central sensitization has on functional outcome scores of patients who underwent hip arthroscopy at a single institution with a minimum of 2 year follow up. We hypothesize that there will be no relationship between CS and postoperative outcome scores in FAI patients treated with arthroscopic hip surgery.

2

2 Methods

2.1

2.1 Inclusion/exclusion criteria

This retrospective prognostic study was approved by out Institutional Review board (Thomas Jefferson University, Control #20E.396) prior to data collection. Patients over the age of 18 who underwent hip arthroscopy with preoperative as well as 2-year postoperative functional outcome scores were identified through the Multicenter Arthroscopic Study of the Hip (MASH) database. Patients were excluded if (1) were less than 18 years of age, (2) had less than 2-year postoperative functional outcome score, or (3) were unable to be contacted for follow up information.

2.2

2.2 Data collection

Eligible patients for data collection had the following preoperative variables available: Visual Analog Scale (VAS) Pain scores, International Hip Outcome Tool (iHOT), the 13-item Patient Activation Measure (PAM), the 2-item Pain Self-Efficacy Questionnaire (PSEQ2), the Brief Resilience Scale (BRS), and the 12-Item Short Form Survey (SF-12) physical component score and mental component score (PCS and MCS, respectively). Patient medical record review was performed to collect patient demographic and hip arthroscopic procedures information (i.e. acetabuloplasty, labral repair, labral reconstruction, femoraplasty, psoas release, synovectomy, ligament teres debridement, capsulorraphy, capsular closure etc.). Data was also collected for the following postoperative variables: iHOT Score, VAS Pain Score, PCS Score, MCS score, Visual Analog Scale (VAS) Satisfaction Score, and complications.

Using REDCap, surveys were sent to these patients in order to collect their Central Sensitization Inventory (CSI) scores, which is a validated instrument assessing levels of central sensitization. The CSI has 2 components. In Part A, the patient is asked how often he/she experiences each symptom (never, rarely, sometimes, often, or always). Individual items are scored from 0 (never) to 4 (always), resulting in a total score range for all 25 items from 0 to 100 (Appendix A). Part B asks if the patient has been previously diagnosed with any of 7 common CS syndrome-associated diagnoses (tension headaches/migraines, fibromyalgia, irritable bowel syndrome, restless leg syndrome, temporomandibular joint disorder, chronic fatigue syndrome, and multiple chemical sensitivities) and three CS-related diagnoses (depression, anxiety/panic attacks, and neck injury) (Appendix B).

2.3

2.3 Statistical analysis

Patients were organized into three groups times based off their resilience scores and CSI scores, respectively. Patients were categorized by CSI using the following method. The patients that scored below one standard deviation (SD) of the overall average were categorized into the low CSI group, while those who scored one SD above the overall average were categorized into the high CSI group. Those scoring within one SD of the overall average were grouped into the moderate CSI group.9 The same process was repeated to categorize patients based on resilience scores. Comparison of preoperative and postoperative functional outcome scores were made based off these three created groups for resilience scores and CSI, individually. Associated p-values were also collected.

Additional comparison was done to examine the correlation with focus on CSI scores and preoperative and postoperative functional outcome scores. Relationships between the variables were categorized as no relationship, weakly, moderately, or strongly negative or positive. Correlation values of (r) within the absolute value of ±0.250 were considered to have no correlation; r between values of ±0.500 – ±0.750 were considered moderately correlated; values between values of ±0.750 - ±0.999 were considered strongly correlated. Preoperative and postoperative functional outcome scores were also compared with pairwise testing.

Analyzing of continuous data was conducted using ANOVA and analysis of categorical data was conducted using chi-square test. Statistical significance was set at p < 0.05. All statistical analysis was done using R studio (Version 3.6.3, Vienna, Austria).

3

3 Results

In total, 34 patients were eligible to be included in our study (Table 1) that had an average follow up time of 4.02 ± 0.4 years. Of these 34 patients, 70.6 % (24) were female and 29.4 % (10) were male with an average age of 39.8 ± 25.3. The distribution between right or left hip arthroscopy was 52.9 % (18) and 47.1 % (16), respectively. Patients had an average BMI of 26.3 ± 4.0. Of these 34 patients, 35.3 % (12) underwent a concomitant acetabuloplasty, 76.5 % (26) underwent a labral repair, 67.6 % (23) underwent labral reconstruction, and 2.94 % (1) underwent a femoraplasty. One hundred percent (34) patients had capsular closure, 29.4 % (10) had a synovectomy, and only 5.88 % (2) underwent ligament teres debridement.

Table 1 Pre and post-operative outcome scores (PROMs).
Pre OP VAS 5.38 ± 1.95
Pre OP PCS 36.0 ± 8.77
Pre OP MCS 53.7 ± 10.7
Pre OP iHOT 35.3 ± 20.2
BRS Resilience 3.65 ± 0.85
PAM 13 31.4 ± 5.06
PSEQ2 79.2 ± 24.2
Post Op iHOT 36.0 ± 25.7
Post OP PCS 45.4 ± 10.9
Post OP MCS 49.6 ± 11.0
Post OP VAS 3.59 ± 2.68
VAS Satisfaction 74.0 ± 30.2
CSI 30.1 ± 16.0
Follow Up Time (Years) 4.02 ± 0.40

When it came to the Central Sensitization Index (CSI), the average score was 30.1 ± 16.0. When evaluating pre-operative patient reported outcome measures, no relationship was seen between VAS pain and PCS scores (correlation value 0.237 and −0.042, respectively). However, MCS and iHOT scores demonstrated moderately negative correlations (−0.607 and −0.573, respectively) when compared to CSI, indicating that those who are more vulnerable to pain hypersensitivity reported lower scores preoperatively. Similar to preoperative scores, postoperative scores had no correlation with VAS pain scores or PCS scores (0.186 and −0.235, respectively), but did have a strong negative correlation with MCS scores (−0.756). Of note, iHOT scores were found to have a weakly positive correlation with CSI postoperatively (0.326). Other scores taken during the postoperative period time such as VAS Satisfaction, PAM 13, and PSEQ showed weakly negative correlations to CSI (−0.300, −0.494, and −0.495, respectively), while BRS Resilience showed a moderately negative correlation to CSI with a value of −0.556 (Table 2).

Table 2 Correlations between PROMs and central sensitization index scores.
Variable Correlation Value Relationship
Pre OP VAS 0.237 No Relationship
Pre OP PCS −0.042 No Relationship
Pre OP MCS −0.607 Moderately Negative
Pre OP iHOT −0.573 Moderately Negative
Post OP VAS 0.186 No Relationship
Post OP PCS −0.235 No Relationship
Post OP MCS −0.756 Strongly Negative
Post OP iHOT 0.326 Weakly Positive
VAS Satisfaction −0.300 Weakly Negative
BRS Resilience −0.556 Moderately Negative
PAM 13 −0.494 Weakly Negative
PSEQ2 −0.495 Weakly Negative

Pairwise testing showed significant differences between VAS Pain scores (p = 0.002), PCS scores (p = 0.001), and MCS scores (p = 0.024) preoperatively compared to postoperatively. Interestingly, iHOT scores did not demonstrate a significant difference from pre-operatively to post-operatively (p = 0.726) (Table 3).

Table 3 Comparison of pre and post-operative PROMs.
Variable P Value
VAS 0.002
PCS 0.001
MCS 0.024
iHOT 0.726

Patients were stratified by CSI scores into Low CSI, Moderate CSI, and High CSI groups (Table 4). Notable scores that showed significant differences across all 3 groups were preoperative MCS (p < 0.001), postoperative MCS (p = 0.001), and PSEQ2 (p = 0.015). Postoperative VAS pain approached significance but did not meet criteria of p < 0.05 (p = 0.062).

Table 4 Subgroup analysis of PROMs by central sensitization scores.
Low CSI Moderate CSI High CSI P Value
N = 6 N = 24 N = 4
Pre OP VAS 4.27 (1.88) 5.61 (1.95) (*) 0.294
Pre OP PCS 35.9 (5.53) 36.2 (9.78) 35.6 (8.93) 0.993
Pre OP MCS 62.8 (3.27) 54.1 (8.71) 38.2 (11.4) <0.001
Pre OP iHOT 49.0 (16.6) 35.1 (19.2) 9.74 (10.1) 0.073
Post Op iHOT 2.02 (2.89) 3.81 (2.53) 4.65 (3.05) 0.246
Post OP PCS 50.5 (9.08) 44.4 (10.8) 43.6 (14.6) 0.458
Post OP MCS 57.4 (4.96) 50.4 (10.2) 33.4 (3.51) 0.001
Post OP VAS 17.7 (27.3) 37.3 (22.9) 55.6 (28.7) 0.062
VAS Satisfaction 89.5 (19.7) 74.1 (26.8) 50.2 (51.5) 0.132
BRS Resilience 4.25 (0.88) 3.57 (0.77) 3.21 (1.02) 0.115
PAM 13 34.5 (4.04) 31.2 (5.04) 28.2 (5.12) 0.146
PSEQ2 97.8 (3.66) 78.8 (22.8) 54.2 (30.5) 0.015
CSI 8.33 (4.27) 30.8 (9.93) 58.2 (3.86) <0.001
4

4 Discussion

Central sensitization can occur in patients with chronic hip pain due to various conditions such as labral tears, FAI or osteoarthritis. The persistent nociceptive pain stimuli from the hip joint can lead to the described changes in biochemistry of our patients who display characteristics of Central Sensitization Syndrome (CSS). In 2012, Mayer et al. initially developed the CSI as a self-reporting tool to help identify patients with somatic and emotional complaints that fall within the spectrum of diseases associated with CSS.10 With the highest score achievable set as 100 (25 prompts worth 4 points each), previous literature amongst chronic pain patients found a “cut off” score of 40 is correlated with 81 % sensitivity of correctly identifying patients with CSS disorders.11

To our knowledge this is the first study of its kind to explore CSI in relationship to both PROMs and BRS with a minimum of 2 year follow up. Within our study, the mean CSI score fell below the 40 point threshold, although 12 patients within our cohort did score above 40 points on the CSI. There is a scarcity of literature exploring the relationship of central sensitization to functional and clinical outcomes in arthroscopy. In a 2021 study, Bech et al. found that numeric pain scores were more closely related to the pain catastrophizing scale. Only after running univariate analysis was the CSI score significantly associated with post-operative pain at 12 weeks.8 Patients with CSI scores above 40 had numeric pain scores 1.5 points higher than those with CSI scores under 40. Similarly, in studying total knee arthroplasty and CS, a group in Korea has published various studies exploring the relationship of CS and post-operative pain as well as functional outcomes.12–14 A 2022 meta-analysis described that patients with CS experienced more severe and persistent pain after surgery than the non-CS group.12 An earlier 2019 prospective randomized control trial that adding Duloxetine to a post-operative pain control regimen decreased pain in post-operative weeks 2–12, although interestingly had no effect in the first two weeks.14

Most notably in our pre-operative analysis, MCS and iHOT scores had a negative correlation to CSI scores. Although there is no published literature exploring the relationship of MCS, CSI, and hip arthroscopy, this relationship is not surprising as patients with lower MCS scores may demonstrate mental health challenges or a reduced quality of life prior to surgery which previously has been found to have poorer surgical outcomes.15 Interestingly the negative relationship between MCS and CSI post operatively became stronger, as compared to iHOT scores which became weakly positive post operatively. The relationship between MCS and CSI is again re-demonstrated in the sub-group analysis pre and post operatively, where those with higher CSI scores had significantly lower MCS scores. One recent study found that patients with low MCS scores pre-operatively were able to reach higher MCS scores post operatively.16 Both of these results speak to the role a patient's mental state can affect outcomes. By performing a surgical procedure to address the key pain generator of our patient population, this decrease in nociceptive input can lead to a down regulation of the central sensitization pathway, decreasing the mental stress on our patient population and thus may explain the relationship of MCS to CSI. With regards to the relationship between iHOT scores and CSI, there has previously been discussion that CS is due to neuropathologic pain and not musculoskeletal pain.17 Thus while the surgery may address a patient's limited function due to their musculoskeletal hip pain, it is possible that a central sensitization may still exist and other therapies should be included in treating patients with CS.

There was no correlation between PCS and VAS scores pre-operatively or post operatively. The lack of correlation in the VAS differs from prior literature which used the numeric rating scale,8 although this may be explained in the fact that the numeric scale asks patients to only identify the intensity of their pain and not necessarily the character in addition to the intensity of the pain as in the VAS.

The relationship between resilience and CS is complex. CS contributes to increased pain perception and has the potential to affect resilience negatively. Conversely, patients with stronger resilience may be able to adapt to and respond to a chronic pain syndrome better than their counterparts with a weaker resilience. Previous studies across arthroscopy disciplines have demonstrated that patients with lower resilience have lower post-operative PROMs.18–20 In our study, pre-operative BRS demonstrated a moderately negative correlation to post-operative CSI, affirming that CSI may help to better identify patients who are at a higher risk of developing chronic pain after hip arthroscopy. Future studies with larger patient cohorts and longer-term follow-up are needed in order to understand this complex relationship and ultimately evaluation potentially modifying interventions that can result in improved outcomes in patients with increased CSI.

4.1

4.1 Limitations

This study is not without limitations. First, the retrospective nature of the study contributes its inherent drawbacks. Additionally, the post-operative administration of the CSI at different time points after two years of follow up is suboptimal as compared to pre-operative administration. This same post-operative administration may cofound patients’ responses as their post-operative PROMs directly affect the CSI. In addition, this was a survey based study, so nonresponse bias exists, although our response rate was 76 % which is acceptable compared to previously published literature.

5

5 Conclusion

This study showed that increased postoperative CSI scores directly correlated with decreased pre-operative and post-operative MCS scores and worse pre-operative resilience in patients undergoing hip arthroscopy. Recognizing the influence of CS on pain perception and resilience on coping with adversity in the recovery period may guide orthopaedic surgeons in developing comprehensive treatment plans to continue to improve surgical outcomes in hip arthroscopy. Further investigation is needed to determine whether CSI is a useful pre-operative tool for identifying at risk patient populations and which modalities are able to modify any potential risk and improve outcomes after hip arthroscopy.

Guardian/patient's consent

Due to the retrospective nature and IRB approval of this study, patient consent was not needed to be gathered before conducting this research.

Funding sources

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Institutional Ethical Committee approval

Not applicable.

CRediT authorship contribution statement

Andres R. Perez: Methodology, data collection, Data curation, Writing – original draft, Writing – review & editing. William F. Baker: data collection, Writing – original draft, Writing – review & editing. Neel K. Patel: data analysis, Writing – review & editing. Henson Destine: data collection, Writing – review & editing. Rahul Muchintala: data analysis, Writing – review & editing. Austin Looney: Conceptualization, Supervision, Writing – review & editing. Patrick Szukics: Conceptualization, Supervision, Writing – review & editing. John P. Salvo: study design, Supervision, oversight, Writing – review & editing.

References

  1. , . Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2-S15.
    [Google Scholar]
  2. , . Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306(5944):686-688.
    [Google Scholar]
  3. , , . The Central Sensitization Inventory and Pain Sensitivity Questionnaire: an exploration of construct validity and associations with widespread pain sensitivity among individuals with shoulder pain. Musculoskelet Sci Pract. 2018;36:61-67.
    [Google Scholar]
  4. , , , , . Effects of central sensitivity syndrome and psychological factors on the clinical features of patients with cervical degenerative disease: a cross-sectional study. Asian Spine J. 2021;15(4):464-471.
    [Google Scholar]
  5. , , , , , . Difference in the impact of central sensitization on pain-related symptoms between patients with chronic low back pain and knee osteoarthritis. J Pain Res. 2019;12:1757-1765.
    [Google Scholar]
  6. , , , , , . Correlation of pain sensitization with muscle strength and angular kinematics in women with patellofemoral pain. Clin Biomech Bristol Avon. 2021;81
    [Google Scholar]
  7. , , , , . Psychological and pain profiles in persons with patellofemoral pain as the primary symptom. Eur J Pain Lond Engl. 2020;24(6):1182-1196.
    [Google Scholar]
  8. , , , , , . The influence of pain catastrophizing and central sensitization on the reported pain after hip arthroscopy. Knee Surg Sports Traumatol Arthrosc Off J ESSKA. 2021;29(9):2837-2842.
    [Google Scholar]
  9. , , , et al . Establishing central sensitization-related symptom severity subgroups: a multicountry study using the central sensitization inventory. Pain Med Malden Mass. 2020;21(10):2430-2440.
    [Google Scholar]
  10. , , , et al . The development and psychometric validation of the central sensitization inventory. Pain Pract Off J World Inst Pain. 2012;12(4):276-285.
    [Google Scholar]
  11. , , , et al . The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14(5):438-445.
    [Google Scholar]
  12. , , , , , . Diagnosis of central sensitization and its effects on postoperative outcomes following total knee arthroplasty: a systematic review and meta-analysis. Diagn Basel Switz. 2022;12(5):1248.
    [Google Scholar]
  13. , , , , , . Minimal clinically important differences for patient-reported outcomes after TKA depend on central sensitization. J Bone Joint Surg Am. 2021;103(15):1374-1382.
    [Google Scholar]
  14. , , , , , , . Duloxetine reduces pain and improves quality of recovery following total knee arthroplasty in centrally sensitized patients: a prospective, randomized controlled study. J Bone Joint Surg Am. 2019;101(1):64-73.
    [Google Scholar]
  15. , , , et al . Effect of baseline mental health on 1-year outcomes after hip arthroscopy: a prospective cohort study. Orthop J Sports Med. 2021;9(8)
    [Google Scholar]
  16. , , , , , , . Improved mental health status and patient-reported outcomes after hip arthroscopy for femoroacetabular impingement. Am J Sports Med. 2023;51(6):1525-1530.
    [Google Scholar]
  17. , , , , . The impact of psychological factors and their treatment on the results of total knee arthroplasty. J Bone Joint Surg Am. 2021;103(18):1744-1756.
    [Google Scholar]
  18. , , , . The resilient athlete: lessons learned in the military. Sports Med Arthrosc Rev. 2019;27(3):124-128.
    [Google Scholar]
  19. , , , , , . Preoperative resilience strongest predictor of postoperative outcome following an arthroscopic bankart repair. Orthop J Sports Med. 2017;5(3_suppl 3)
    [Google Scholar]
  20. , , , , , . Associating outcomes after hip arthroscopy with patient resilience. Orthop J Sports Med. 2023;11(2)
    [Google Scholar]
Show Sections